What is the P/E ratio of Maestros Mediline Systems?

The latest standalone P/E ratio of Maestros Mediline Systems as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Maestros Mediline Systems?

The latest standalone P/B ratio of Maestros Mediline Systems as of 01-Jan-1970 is -0.31.

Maestros Mediline Systems Ltd - Stock Valuation and Financial Performance

Name: Maestros Mediline Systems
Brand: Maestros Mediline Systems

BSE: 501209 | NSE: | Medical Equipment/Supplies/Accessories | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Maestros MedilineSys

Based on:

Data

M-Cap below 100cr DeciZen not available

Maestros Mediline Systems stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

4.6 Cr.

52-wk low:

10.4

52-wk high:

10.4

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Maestros MedilineSys:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	TTM
ROCE % ⓘ	3.7%	7.7%	6.8%	6.4%	11.9%	11.1%	-19.6%	-31.5%	-80%	-18.5%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	25	33.8	27.6	28.1	39.1	32.3	9.8	7	4.2	0.6	1
Sales YoY Gr.	-	34.9%	-18.3%	2%	38.8%	-17.4%	-69.6%	-28.5%	-39.7%	-86.8%	-
Adj EPS ⓘ	1.5	2.8	0.5	0.2	6.2	4.3	-33.2	-31.5	-51	-6.9	-6.9
YoY Gr.	-	92.5%	-83.6%	-58.7%	3152.6%	-30.3%	-870.3%	NA	NA	NA	-
BVPS (₹) ⓘ	75	78.4	80.4	81.6	87.6	37.1	4.1	-29.4	-82.2	-89	-33.5
Adj Net Profit ⓘ	0.7	1.3	0.2	0.1	2.7	1.9	-14.5	-13.8	-22.3	-3	-3
Cash Flow from Ops. ⓘ	-4.2	13.3	7.3	3.3	2.6	-5.9	-9.5	0.5	-0.3	0	-
Debt/CF from Ops. ⓘ	-2.5	0.3	1.1	2.3	4.5	-6.3	-5.2	104.4	-200.7	1650.9	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-34.4%	-57.2%	-61.5%	-86.8%
Adj EPS ⓘ	-218.8%	-202.1%	NA	NA
BVPSⓘ	-201.9%	-200.3%	-378.7%	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	TTM
Return on Equity % ⓘ	1.9	3.6	0.6	0.2	7.3	6.9	-161.2	249.1	91.4	8	11.2
Op. Profit Mgn % ⓘ	13.3	12.7	12.7	12.7	18.9	22.7	-93.1	-171.4	-509	-433.6	-33
Net Profit Mgn % ⓘ	2.7	3.8	0.7	0.3	6.9	5.8	-147.8	-196.2	-527.3	-539	-536.1
Debt to Equity ⓘ	0.3	0.1	0.2	0.2	0.3	2.3	27.6	-4	-1.5	-1.4	-
Working Cap Days ⓘ	389	330	385	404	322	465	1,868	2,588	2,294	6,077	904
Cash Conv. Cycle ⓘ	183	151	168	143	125	210	1,070	1,334	1,055	1,225	68

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Maestros Mediline Systems Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-6.9	-6.9
TTM Sales (₹ Cr.)	0.6	0.6
BVPS (₹.) ⓘ	-33.5	-91.7
Reserves (₹ Cr.) ⓘ	-19	-44
P/BV ⓘ	-0.31	-0.11
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	10.44 / 10.44
All Time Low / High (₹)	3.50 / 81.75
Market Cap (₹ Cr.)	4.6
Equity (₹ Cr.)	4.4
Face Value (₹)	10
Industry PE ⓘ	78.9

Management X-Ray of Maestros MedilineSys:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

57.37

0.00

57.37

56.45

* Pledged shares as % of Promoter's holding (%)

Valuation of Maestros MedilineSys

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Maestros MedilineSys

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16
Sales	25.02	33.76	27.59	28.14	39.06	32.26	9.82	7.02	4.23	0.56
Operating Expenses ⓘ	21.83	29.51	24.10	24.57	31.98	24.93	18.97	20.31	25.74	2.97
Manufacturing Costs	0.73	0.72	0.59	0.59	0.65	0.37	0.57	0.32	0.11	0.17
Material Costs	13.26	19.09	12.50	13.37	19.98	12.04	10.02	12.97	5.18	0.79
Employee Cost	3.76	4.67	5.59	5.82	6.32	7.06	5.83	3.12	1.64	1.60
Other Costs ⓘ	4.07	5.03	5.42	4.80	5.03	5.46	2.55	3.89	18.81	0.41
Operating Profit ⓘ	3.20	4.25	3.49	3.57	7.08	7.33	-9.15	-13.29	-21.51	-2.42
Operating Profit Margin (%)	12.8%	12.6%	12.6%	12.7%	18.1%	22.7%	-93.1%	-189.0%	-509.0%	-433.0%
Other Income ⓘ	0.08	0.28	0.59	0.95	0.80	0.22	0.75	0.17	0.04	0.14
Interest ⓘ	0.79	1.59	1.83	2.39	2.94	4	5.38	0.55	0.03	0.02
Depreciation ⓘ	1.76	1.26	1.24	1.73	2.34	1.81	1.88	1	0.79	0.70
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.72	1.68	1	0.40	2.60	1.74	-15.66	-14.66	-22.29	-3
Tax ⓘ	0.15	0.43	0.80	0.18	0.10	-0.14	-1.25	0	0	0
Profit After Tax	0.57	1.25	0.20	0.22	2.50	1.88	-14.41	-14.66	-22.29	-3
PAT Margin (%)	2.3%	3.7%	0.7%	0.8%	6.4%	5.8%	-146.0%	-208.0%	-527.0%	-538.0%
Adjusted EPS (₹)	1.3	2.7	0.5	0.5	5.7	4.3	-33.0	-33.5	-51.0	-6.9
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16
Equity and Liabilities
Shareholders Fund	34.93	36.18	35.79	35.81	38.31	16.21	1.80	-12.86	-35.93	-38.93
Share Capital ⓘ	4.55	4.55	4.42	4.37	4.37	4.37	4.37	4.37	4.37	4.37
Reserves ⓘ	30.38	31.63	31.38	31.44	33.94	11.84	-2.58	-17.23	-40.30	-43.30
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	10.47	4.39	7.79	7.50	11.73	37.08	49.62	51.04	53.40	53.67
Long Term Debt	10.47	4.39	7.79	7.50	3.55	22.87	29.93	30.01	29.88	29.94
Short Term Debt	0	0	0	0	8.18	14.21	19.69	21.04	23.51	23.73
Trade Payables	4.15	5.99	6.03	8.85	8.01	9.66	10	8.91	1.51	3.33
Others Liabilities ⓘ	10.41	12.54	17.33	16.85	15.72	9.58	13.06	10.74	3.88	4.34
Total Liabilities ⓘ	59.96	59.10	66.93	69	73.77	72.54	74.47	57.83	22.86	22.42
Fixed Assets
Gross Block	30.52	31.44	37.55	39.46	44.75	23.97	25.01	17.77	16.99	16.99
Accumulated Depreciation	7.49	8.34	9.57	11.31	13.62	8.74	10.62	4.32	5.10	5.80
Net Fixed Assetsⓘ	23.03	23.10	27.97	28.16	31.13	15.23	14.39	13.45	11.88	11.19
CWIP ⓘ	0.34	0.18	0.36	0	0	7.40	0	0	0	0
Investmentsⓘ	0.31	4.61	1.03	1.03	1.54	0.73	0.73	0.01	0.01	0.01
Inventories	7.92	8.40	8.09	10.31	13.01	13.66	12.13	2.39	0.57	0.15
Trade Receivables	11.14	14.11	10.69	11.71	13.51	21.11	22.39	25	2.56	1.87
Cash Equivalents	1.33	1.73	7.42	6.28	4.13	3.78	0.99	1.27	0.52	0.70
Others Assetsⓘ	15.89	6.98	11.37	11.52	10.45	10.62	23.84	15.71	7.32	8.49
Total Assets ⓘ	59.96	59.10	66.93	69	73.77	72.54	74.47	57.83	22.86	22.42

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16
Cash Flow From Operating Activity ⓘ	-4.19	13.34	7.28	3.28	2.59	-5.93	-9.51	0.49	-0.27	0.03
PBT ⓘ	0.72	1.68	1	0.40	2.60	1.74	-15.66	-14.66	-22.29	-3
Adjustment ⓘ	3.01	2.93	3.20	4.26	5.40	5.81	6.70	3.76	19.14	0.66
Changes in Working Capital ⓘ	-7.91	8.73	3.09	-1.37	-5.42	-13.48	-0.55	11.39	2.88	2.37
Tax Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	-1.02	-5.46	-2.57	-1.54	-5.83	-14.55	-1.57	0.42	-0.38	0.11
Capex	0.04	0.02	0	0	0.02	0	0	0	0	0
Net Investments	0.07	-4.30	3.58	0	0	0	0	0	0	0
Others ⓘ	-1.13	-1.19	-6.15	-1.54	-5.86	-14.55	-1.57	0.42	-0.38	0.11
Cash Flow From Financing Activityⓘ	5.80	-7.48	0.98	-2.88	1.29	21.96	7.50	-0.26	-0.14	0.04
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	6.56	-6.08	0	0	4.23	0	0	0	0	0
Interest Paid ⓘ	-0.76	-1.39	-1.83	-2.39	-2.94	-4	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	2.82	-0.49	0	25.96	7.50	-0.26	-0.14	0.04
Net Cash Flow ⓘ	0.60	0.40	5.69	-1.14	-1.95	1.48	-3.59	0.65	-0.79	0.18

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16
Ratios
ROE (%)	1.69	3.58	0.56	0.61	6.76	6.91	-160.07	N/A	N/A	N/A
ROCE (%)	3.71	7.72	6.8	6.43	11.88	11.11	-19.63	N/A	N/A	N/A
Asset Turnover Ratio	0.48	0.59	0.44	0.42	0.56	0.44	0.14	0.11	0.11	0.03
PAT to CFO Conversion(x)	-7.35	10.67	36.4	14.91	1.04	-3.15	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	138	132	162	143	116	196	783	1,209	1,181	1,285
Inventory Days	108	85	108	117	107	151	464	370	127	209
Payable Days	98	97	175	203	154	268	358	266	367	1,121

Maestros Mediline Systems Ltd Stock News

Maestros Mediline Systems Ltd FAQs

What is the share price of Maestros MedilineSys?

Company share prices are keep on changing according to the market conditions. The closing price of Maestros MedilineSys on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Maestros MedilineSys?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Maestros MedilineSys stood at ₹4.57.

What is the P/E ratio of Maestros MedilineSys?

The latest P/E ratio of Maestros MedilineSys as of 01-Jan-1970 05:30 is 0.00.

What is the P/B ratio of Maestros MedilineSys?

The latest P/B ratio of Maestros MedilineSys as of 01-Jan-1970 05:30 is -0.31.

What is the 52-week high and low of Maestros MedilineSys?

The 52-week high of Maestros MedilineSys is ₹10.44 and the 52-week low is ₹10.44.

What is the TTM revenue of Maestros MedilineSys?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Maestros MedilineSys is ₹0.56 ( Cr.) .

About Maestros Mediline Systems Ltd

Maestros Mediline Systems Ltd. ever since its beginning in 1992 has carved a niche in competitive fields of cardiological & gynecological equipment. The company has 10 offices across the sub-continent and about 200+ employees to provide prompt sales & support to customers.They have their manufacturing works at Navi Mumbai (Maharashtra) and Parwanoo (Himachal Pradesh).

All their products are delicately planned, designed and developed with combined dedicated efforts by their team that includes biomedical engineers, designers, doctors and other expertise to bring forth the latest technology.They also proudly acknowledge that they have designed, developed and launched recently, state-of-the-art telemedicine products like complete telemedicine software, event recorders, telemedicine peripherals etc.

Maestros has installed its equipment throughout the length & breadth of the sub-continent by many World Bank assisted State Health Systems Development Projects (Punjab Health Systems Corporation, Orissa Health Systems Development Project, Uttar Pradesh Health Systems Development Project, Maharashtra Health Systems Development Project, Kerala Health Systems Development etc). These World Bank assisted orders and distinguished private institutions / Government bodies have further motivated Maestros vision to become a globally renowned organization and continue designing World Class equipment.

On its focus to go global, Maestros has already started their distinct network in Far East / Middle East / Egypt and already has 500+ installations outside India in a short span of 1 year.

Product range of the company includes:

Cardiology

ECG Recorders
Stress Test System
Spirometers
Defibrillator

Gynecology

Portable Fetal Monitors
Monitoring
Pulse Oximeters
Patient Monitors
Central Monitoring Station

Ultrasound

Sonomagic

Infusion Pump

Syringe Pump

Telemedicine

Milestones:

1992 Maestros started its operations in medical electronics in Juhu, a suburb in Mumbai.
1993 Moved to new premises at Neelam Center, Worli. Established the company as a value-added professional with Sonata.
1994 Became the third solution provider to Microsoft in India.
1995 Started Training operations and became the Authorized Training Center for Microsoft.
1996 Became a Support Center for Microsoft and moved into Consultancy.
1997 Expanded the distribution network for the Medical Electronics Division. Started operations at Bangalore and Pune
1998 Converted into a Public company. Formed the corporate office in Mumbai and established a zonal office in Bangalore.
1999 Acquired the IEC 601 certification for Medical Embedded Systems. Built up a factory structure for Medical Embedded Systems for full fledged production activity. Opened a branch office in Pune.
2000 Opened a zonal office in Delhi. Started operations in Ahmedabad, Bhopal, Lucknow, Chandigarh and Cochin.
2001 Acquired additional premises at Silvassa for enhancing production activities. Obtained the ISO 9001:2000 accreditation from Bureau Veritas Quality International. Opened a branch office at Lucknow and Hyderabad.
2002 Started Eastern zone operations. Started additional manufacturing unit at Silvassa (Gujarat).
2003 Registered with Bombay Stock Exchange.
2004 Initiated export operations in South East Asia & Middle East.
2005 Started factory in Parwanoo, Himachal Pradesh. Obtained ISO 13485:2003 from Orion Registrar, Inc. CE mark for ECG machine. Introduced Telemedicine products and software.
2006 Expanded existing manufacturing unit in Mahape, Navi Mumbai for manufacturing and R&D activities. Introduced Embedded Systems & executed projects for corporates.